Cargando…

Access to pain treatment as a human right

BACKGROUND: Almost five decades ago, governments around the world adopted the 1961 Single Convention on Narcotic Drugs which, in addition to addressing the control of illicit narcotics, obligated countries to work towards universal access to the narcotic drugs necessary to alleviate pain and sufferi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohman, Diederik, Schleifer, Rebecca, Amon, Joseph J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823656/
https://www.ncbi.nlm.nih.gov/pubmed/20089155
http://dx.doi.org/10.1186/1741-7015-8-8
_version_ 1782177656246108160
author Lohman, Diederik
Schleifer, Rebecca
Amon, Joseph J
author_facet Lohman, Diederik
Schleifer, Rebecca
Amon, Joseph J
author_sort Lohman, Diederik
collection PubMed
description BACKGROUND: Almost five decades ago, governments around the world adopted the 1961 Single Convention on Narcotic Drugs which, in addition to addressing the control of illicit narcotics, obligated countries to work towards universal access to the narcotic drugs necessary to alleviate pain and suffering. Yet, despite the existence of inexpensive and effective pain relief medicines, tens of millions of people around the world continue to suffer from moderate to severe pain each year without treatment. DISCUSSION: Significant barriers to effective pain treatment include: the failure of many governments to put in place functioning drug supply systems; the failure to enact policies on pain treatment and palliative care; poor training of healthcare workers; the existence of unnecessarily restrictive drug control regulations and practices; fear among healthcare workers of legal sanctions for legitimate medical practice; and the inflated cost of pain treatment. These barriers can be understood not only as a failure to provide essential medicines and relieve suffering but also as human rights abuses. SUMMARY: According to international human rights law, countries have to provide pain treatment medications as part of their core obligations under the right to health; failure to take reasonable steps to ensure that people who suffer pain have access to adequate pain treatment may result in the violation of the obligation to protect against cruel, inhuman and degrading treatment.
format Text
id pubmed-2823656
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28236562010-02-18 Access to pain treatment as a human right Lohman, Diederik Schleifer, Rebecca Amon, Joseph J BMC Med Debate BACKGROUND: Almost five decades ago, governments around the world adopted the 1961 Single Convention on Narcotic Drugs which, in addition to addressing the control of illicit narcotics, obligated countries to work towards universal access to the narcotic drugs necessary to alleviate pain and suffering. Yet, despite the existence of inexpensive and effective pain relief medicines, tens of millions of people around the world continue to suffer from moderate to severe pain each year without treatment. DISCUSSION: Significant barriers to effective pain treatment include: the failure of many governments to put in place functioning drug supply systems; the failure to enact policies on pain treatment and palliative care; poor training of healthcare workers; the existence of unnecessarily restrictive drug control regulations and practices; fear among healthcare workers of legal sanctions for legitimate medical practice; and the inflated cost of pain treatment. These barriers can be understood not only as a failure to provide essential medicines and relieve suffering but also as human rights abuses. SUMMARY: According to international human rights law, countries have to provide pain treatment medications as part of their core obligations under the right to health; failure to take reasonable steps to ensure that people who suffer pain have access to adequate pain treatment may result in the violation of the obligation to protect against cruel, inhuman and degrading treatment. BioMed Central 2010-01-20 /pmc/articles/PMC2823656/ /pubmed/20089155 http://dx.doi.org/10.1186/1741-7015-8-8 Text en Copyright ©2010 Lohman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Debate
Lohman, Diederik
Schleifer, Rebecca
Amon, Joseph J
Access to pain treatment as a human right
title Access to pain treatment as a human right
title_full Access to pain treatment as a human right
title_fullStr Access to pain treatment as a human right
title_full_unstemmed Access to pain treatment as a human right
title_short Access to pain treatment as a human right
title_sort access to pain treatment as a human right
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823656/
https://www.ncbi.nlm.nih.gov/pubmed/20089155
http://dx.doi.org/10.1186/1741-7015-8-8
work_keys_str_mv AT lohmandiederik accesstopaintreatmentasahumanright
AT schleiferrebecca accesstopaintreatmentasahumanright
AT amonjosephj accesstopaintreatmentasahumanright